Top Markets
Coin of the day
Medlab Clinical Limited Medlab Clinical Limited

Medlab Clinical Limited

MDC
Rang in aandelen #32244
Medlab Clinical Limited is an Australian biotechnology firm dedicated to the... Medlab Clinical Limited is an Australian biotechnology firm dedicated to the research, development, and initial commercialization of innovative pharmaceutical and nutraceutical products. Its pipeline features key drug candidates such as NanaBis, a buccal spray derived from cannabis oil extract, intended for use in oncology and pain management. Another significant candidate is NanoCBD, a buccal spray sourced from hemp oil extract, aimed at supporting mental well-being. A core innovation is NanoCelle, a proprietary sub-micron drug delivery platform that enables the direct passive diffusion of active pharmaceutical ingredients into the bloodstream through diverse administration methods including oral-buccal, sublingual, intranasal, and transdermal or topical applications. The company also extends its offerings to include virtual clinic services. Founded in 2012, Medlab Clinical Limited is headquartered in Botany, Australia.
Aandeelprijs
$4.65
Laatst gesynchroniseerd: 2024-07-24
Marktkapitalisatie
$10.63M
Verandering (1 dag)
6.66%
Verandering (1 jaar)
0.00%
Land
AU
Handel Medlab Clinical Limited (MDC)

Categorie

Koersgeschiedenis voor Medlab Clinical Limited (MDC)
Hoogste slotkoers: $4.65 op 2024-07-01

Laagste slotkoers: $20.06 op 2015-07-01
Koersgeschiedenis van Medlab Clinical Limited van 2015 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2024 5.52%
2023 -8.38%
2022 -69.42%
2021 -45.35%
2020 -15.13%
2019 -18.05%
2018 -52.21%
2017 -8.72%
2016 360.38%
2015 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$515.58 32.24%
US
$992.01 50.00%
NL
$111.17 -36.90%
AU
$736.64 6.99%
CH
$1.06K -6.61%
KR